Sr. Medical Director, Drug Safety & Pharmacovigilance
Scholar Rock· Cambridge, MA
hybrid director $280k – $420k / year seen live 2 days ago
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need. As a global leader in myostatin biology, a field focused on proteins
This link goes straight to the employer's lever page. Posted 447 days ago.We last confirmed it was open 2 days ago.